期刊文献+

肺纤通及其拆方对肺间质纤维化模型大鼠Th1/Th2细胞因子的影响 被引量:9

下载PDF
导出
摘要 目的:初步探讨肺纤通治疗特发性肺间质纤维化(IPF)的作用途径,研究治疗IPF的最佳中药配伍。方法:通过肺纤通及其拆方对IPF模型大鼠的干预,观察各组大鼠肺泡炎及肺纤维化分级情况,以及Th1/Th2失衡程度。结果:模型组大鼠肺纤维化病理改变较重,肺泡炎改变较轻。而各治疗组与模型组比较,肺纤维化改善较为明显。Th1/Th2的代表细胞因子显示,各治疗组大鼠血清IL-4水平有下降趋势,IFN-γ水平有上升趋势,较模型组有所改善。拆方组中,含有软坚药的拆方组较活血组和益气组改善明显;单用活血药作用不明显,但活血药与软坚药配伍后疗效明显增强。结论:肺纤通可能有延缓肺泡炎向纤维化进展的作用,其中全方组疗效最好。
出处 《江苏中医药》 CAS 北大核心 2008年第7期78-80,共3页 Jiangsu Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(30340076) 国家中医药管理局课题资助项目(02-03LP52)
  • 相关文献

参考文献8

  • 1Kunkel SL,.Chensue SW,Lukacs N,et al.Cytokine phenotypes serve' as a paradigm for experimental immune-mediated lung disease and remodeling,Am J Respir Cell Mol Biol,2003,29: $63
  • 2Clark JG,Kostal KM,Marino BA.Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macropha-ge product increase fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast prolifera-tion and collagen production. J Clin Invest,1983,72(6) :2082
  • 3陈佰义,姜莉,赵洪文,吕长俊,侯显明.博莱霉素致大鼠肺纤维化肺泡巨噬细胞氧化和抗氧化损伤的动态研究[J].中国医科大学学报,1995,24(3):240-242. 被引量:17
  • 4Szapiel SV,Elson NA,Fulmur JD,et al. Bleomycin-induced interstitial pulmonary disease in the nude,athymic mouse,Am Rev Respir Dis, 1979,120:893
  • 5Ulloa L,Doody J,Massague J.Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway, Nature, 1999,6721 ( 397 ) : 710
  • 6陈莹,董静,陈杰.γ-干扰素对矽肺大鼠肺脏白介素-4和转化生长因子-β_1蛋白表达的影响[J].中华劳动卫生职业病杂志,2004,22(5):350-353. 被引量:7
  • 7Huaux F,Liu T,McGarry B,et al,Dual roles of IL-4 in lung injury and fibrosis.J Immunol,2003,170(4):2083
  • 8Jakubzick C,Choi ES,Joshi BH,et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4-and IL-13-responsive cells, J Immunol,2003,171 (5) :2864

二级参考文献10

  • 1夏奕明,卫生研究,1987年,16卷,40期,29页
  • 2Lukacs NW, Hogaboam C, Chensue SW, et al. Typel/type2 cytokine paradigm and the progression of pulmonary fibrosis. Chest, 2001,120( 1Suppl): 5S-8S.
  • 3Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J, 1998,11:1218-1221.
  • 4Maeyama T, Kuwano K, Kawasaki M, et al. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12.Am J Physiol Lung Cell Mol Physiol, 2001,280:1128-1137.
  • 5Jaffe HA, Gao Z, Mori Y, et al. Selective inhibition of collagen gene expression in fibroblasts by an interferon-y transgene. Exp Lung Res,1999,25:199-215.
  • 6Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta ( 1 )and interferon-gamma. Am J Physiol Lung Cell Mol Physiol,2002,283:L806-814.
  • 7Sime PJ, O' Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001,99:308-319.
  • 8Lasky JA, Brody AR. Interstitial fibrosis and growth factors. Environ Health Perspect, 2000,108 ( Suppl 4): 751-762.
  • 9Roberts AB, Piek E, Bottinger EP, et al. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest,2001,120(1Suppl) :43S-47S.
  • 10Attisano L, Wrana JL. Mads and Smads in TGF beta signalling. Curr Opin Cell Biol, 1998,10:188-194.

共引文献22

同被引文献95

引证文献9

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部